Oncothyreon (ONTY) Misses Q4 EPS by 21c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. AMGN
3. BKNG
4. DOX
5. DUOL
6. ANET
7. SWKS
8. XYZ
9. FISV
10. CVS

Go back to Oncothyreon (ONTY) Misses Q4 EPS by 21c

Jefferies Starts Oncothyreon (ONTY) at Buy; Sees 49% Upside

March 12, 2015 6:42 AM EDT

Jefferies initiates coverage on Oncothyreon (NASDAQ: ONTY) with a Buy rating and a price target of $2.50, suggesting 49% upside to yesterday's close.

Analyst Biren Amin commented, "ONTY's ONT-380 has shown encouraging efficacy in PI trials and differentiates itself from competitors on safety. ONTY is further... More